The global Pancreatic Stone Protein Testing Market stood at USD 2.30 Billion in 2026 and is forecast to reach USD 2.89 Billion by 2036, expanding at a CAGR of 2.3% over the decade. This growth reflects increasing clinical adoption of pancreatic stone protein (PSP) as an early biomarker for sepsis and infection-driven organ dysfunction, enabling detection...